The antitumor effect of cyclooxygenase-2-derived prostaglandin E2 (PGE2) is based on a variety of mechanisms, including direct stimulation of cancer cell growth and neovascularization (neovascularization) [22, 23]. This evidence concerns the gene PTGS2 and cancer.